A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression

Abstract

<div class="section"> <a class="named-anchor" id="d3744470e148"> <!-- named anchor --> </a> <h5 class="section-title" id="d3744470e149">Study Objectives:</h5> <p id="d3744470e151">A single-item sleep quality scale (SQS) was developed as a simple and practical sleep quality assessment and psychometrically evaluated. </p> </div><div class="section"> <a class="named-anchor" id="d3744470e153"> <!-- named anchor --> </a> <h5 class="section-title" id="d3744470e154">Methods:</h5> <p id="d3744470e156">SQS measurement characteristics were evaluated using the Pittsburgh Sleep Quality Index (PSQI) and morning questionnaire-insomnia (MQI) according to prespecified analysis plans in separate clinical studies of patients with insomnia and depression. Patients with insomnia (n = 70) received 4 weeks' usual care with an FDA-approved hypnotic agent; patients with depression (n = 651) received 8 weeks' active or experimental therapy. </p> </div><div class="section"> <a class="named-anchor" id="d3744470e158"> <!-- named anchor --> </a> <h5 class="section-title" id="d3744470e159">Results:</h5> <p id="d3744470e161">Concurrent criterion validity (correlation with measures of a similar construct) was demonstrated by strong (inverse) correlations between the SQS and MQI (week 1 Pearson correlation −.76) and PSQI (week 8 Goodman-Kruskal correlation −.92) sleep quality items in populations with insomnia and depression, respectively. In patients with depression, stronger correlations between the SQS and PSQI core sleep quality components versus other items supported convergent/divergent construct validity (similarity/dissimilarity to related/unrelated measures). Known-groups validity was evidenced by decreasing mean SQS scores across those who sleep normally, those borderline to having sleep problems, and those with problems sleeping. Test-retest reliability (intraclass correlation coefficient) was .62 during a 4-week period of sleep stability in patients with insomnia and .74 in stable patients with depression (1 week). Effect sizes (standardized response means) for change from baseline were 1.32 (week 1) and .67 (week 8) in populations with insomnia and depression, respectively. Mean SQS changes from baseline to week 8 convergently decreased across groups of patients with depression categorized by level of PSQI sleep quality improvement. </p> </div><div class="section"> <a class="named-anchor" id="d3744470e163"> <!-- named anchor --> </a> <h5 class="section-title" id="d3744470e164">Conclusions:</h5> <p id="d3744470e166">The SQS possesses favorable measurement characteristics relative to lengthier or more frequently administered sleep questionnaires in patients with insomnia and depression. </p> </div><div class="section"> <a class="named-anchor" id="d3744470e168"> <!-- named anchor --> </a> <h5 class="section-title" id="d3744470e169">Clinical Trial Registration:</h5> <p id="d3744470e171">Registry: ClincalTrials.gov, Title: Treatment of Patients With Major Depressive Disorder With MK0869, Identifier: NCT00034983, URL: <a data-untrusted="" href="https://clinicaltrials.gov/ct2/show/NCT00034983" id="d3744470e173" target="xrefwindow">https://clinicaltrials.gov/ct2/show/NCT00034983</a> </p> </div><div class="section"> <a class="named-anchor" id="d3744470e176"> <!-- named anchor --> </a> <h5 class="section-title" id="d3744470e177">Citation:</h5> <p id="d3744470e179">Snyder E, Cai B, DeMuro C, Morrison MF, Ball W. A new single-item sleep quality scale: results of psychometric evaluation in patients with chronic primary insomnia and depression. <i>J Clin Sleep Med.</i> 2018;14(11):1849–1857. </p> </div>